Nilsine Partners, LLC Argenx Se Transaction History
Nilsine Partners, LLC
- $1.15 Trillion
- Q4 2025
A detailed history of Nilsine Partners, LLC transactions in Argenx Se stock. As of the latest transaction made, Nilsine Partners, LLC holds 3,653 shares of ARGX stock, worth $3.32 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
3,653Holding current value
$3.32 Million% of portfolio
0.27%Shares
1 transactions
Others Institutions Holding ARGX
# of Institutions
535Shares Held
26MCall Options Held
589KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...